Sunday January 21st 2018

Archive for April, 2017

New data at AAN reinforce clinical benefit of Roche’s OCREVUS ™ (ocrelizumab) for relapsing and primary progressive multiple sclerosis

New data at AAN reinforce clinical benefit of Roche’s OCREVUS ™ (ocrelizumab) for relapsing and primary progressive multiple sclerosis

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data from the OCREVUS™ (ocrelizumab) clinical trial programmes will be presented during the 69th American Academy of Neurology (AAN) Annual Meeting in Boston, Massachusetts. The presentations will highlight new [Read More]

New data at AAN reinforce clinical benefit of Roche ‘ s OCREVUS ™ (ocrelizumab) for relapsing and primary progressive multiple sclerosis

New data at AAN reinforce clinical benefit of Roche ‘ s OCREVUS ™ (ocrelizumab) for relapsing and primary progressive multiple sclerosis

Roche announced today that new data from the OCREVUS ™ (ocrelizumab) clinical trial programmes will be presented during the 69th American Academy of Neurology (AAN) Annual Meeting in Boston, Massachusetts. (Source: Roche Media News)MedWorm Sponsor Message: Directory of [Read More]

Lower physical activity in persons with multiple sclerosis at increased fall risk: a cross-sectional study – Sebasti ão E, Learmonth YC, Motl RW.

Lower physical activity in persons with multiple sclerosis at increased fall risk: a cross-sectional study – Sebasti ão E, Learmonth YC, Motl RW.

This study investigated PA levels in persons with MS as a function of fall risk categories. Forty-seven persons with ... (Source: SafetyLit) [Read More]

 Page 4 of 24  « First  ... « 2  3  4  5  6 » ...  Last » 

Latest Topics

Government Shutdown’s Impact on People with MS

Government Shutdown’s Impact on People with MS

/About-the-Society/News/Government-Shutdown-s-Impact-on-People-with-MS [Read More]

Researchers unravel key molecular mechanism of autoimmune and inflammatory diseases

Researchers unravel key molecular mechanism of autoimmune and inflammatory diseases

An international team of researchers led by prof. Savvas Savvides has unraveled a crucial aspect of the molecular basis [Read More]

Kessler Foundation wins $735,000 grant for training rehabilitation researchers

Kessler Foundation wins $735,000 grant for training rehabilitation researchers

Guang Yue, PhD, director of Human Performance and Engineering Research at Kessler Foundation, has been awarded a [Read More]

6,000-year-old track record for healing leaky gut

6,000-year-old track record for healing leaky gut

When I was traveling in India, I had the privilege of studying Ayurvedic medicine with traditional Master Healers. [Read More]

Study shows high-salt diet causes dementia in mice

Study shows high-salt diet causes dementia in mice

A high-salt diet reduces resting blood flow to the brain and causes dementia in mice, according to a new study by [Read More]